Form 4: GoodRx Holdings Chief Accounting Officer Romin Nabiey Reports Stock Transactions

GoodRx Holdings' Chief Accounting Officer, Romin Nabiey, executed transactions involving Class A common stock and restricted stock units, as detailed in a recent SEC Form 4 filing.

Summary

• Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, reported transactions on November 8, 2024.
• These transactions included the acquisition of 12,663 Class A common stock shares through the vesting of restricted stock units.
• Additionally, 4,519 Class A common stock shares were disposed of to cover tax obligations at a price of $5.04 per share.
• Following these transactions, Nabiey directly owns 82,449 shares of Class A common stock and 126,627 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing insider transactions, which is neither positive nor negative in itself. It reflects standard corporate governance practices.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies like GoodRx Holdings. It provides transparency into the trading activities of company executives.

Comparison to Industry Standards

• SEC Form 4 filings are a standard practice for all publicly traded companies in the United States, ensuring transparency of insider trading.
• The transactions reported are typical for executives who receive stock-based compensation, such as restricted stock units, which vest over time.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are routine insider transactions.
• The filing provides transparency to the market regarding executive stock ownership.

Key Dates

Keywords

GoodRx Holdings, GDRX, SEC Form 4, insider trading, Romin Nabiey, Class A Common Stock, restricted stock units, stock transactions, Chief Accounting Officer